About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDEARLY Phase 1NCT04119063

Evaluating Wearable Robotic Assistance on Gait

The overarching goal of this study is to improve mobility in individuals with movement disorders through advances in wearable assistance (i.e. powered orthoses).

Lead sponsor: Northern Arizona University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Northern Arizona University

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Individuals with cerebral palsy completed high frequency over-ground gait training (4x/week for 1 week) with ankle exoskeleton assistance, and then, after a 1 year washout period, the same participants will complete low frequency over-ground gait training (2x/week for 2 weeks).

Age

5 - 35 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age between 5 and 35 years old, inclusive.
•Either a healthy volunteer or a diagnosis of a neurologically-based walking disorder due to stroke, spinal cord injury, Parkinson's disease, or cerebral palsy.
•Must be able to understand and follow simple directions based on parent report and clinical observation during the history and physical examination.
•Able to provide verbal assent, if appropriate. If the participant is non-verbal, parental interpretation of gesticulation for assent will be used.
•The ability to read and understand English.
•Able to walk at least 30 feet with or without a walking aid (GMFCS Level I-III for individuals with cerebral palsy)

Exclusion Criteria

•Any neurological, musculoskeletal or cardiorespiratory injury, health condition ( including pregnancy), or diagnosis other than stroke, spinal cord injury, Parkinson's disease or cerebral palsy that would affect the ability to walk as directed for short periods of time.

Related studies

Constraint-induced Movement Therapy Combined With Functional Electrical Stimulation in Children With Cerebral Palsy

NCT07587476 · Cerebral Palsy (CP)

Cerebral Palsy and the Study of Brain Activity During Motor Tasks

NCT01829724 · Cerebral Palsy, Children

Investigating New Methods to Study Movement in Children and Young Adults With Movement Disorders.

NCT06498596 · Cerebral Palsy

Complex Rehabilitation Technology Enabled Physical Activity for Children With Motor Delays Via Telehealth in Natural Environments

NCT07252713 · Cerebral Palsy (CP), Motor Disability, and more

A Motor Learning Intervention to Target Walking Performance in Ambulant Children With Cerebral Palsy

NCT06454656 · Cerebral Palsy, Walking, Difficulty, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 10, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseEARLY_PHASE1

Enrollment6

Start dateSep 2019

Last updatedJan 10, 2024

Condition

Locations shown

Northern Arizona University

Flagstaff, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 10, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions